Pharmacokinetics, pharmacodynamics, and tolerability of aleglitazar in patients with type 2 diabetes: results from a randomized, placebo-controlled clinical study.

Pharmacokinetics, pharmacodynamics, and tolerability of aleglitazar in patients with type 2 diabetes: results from a randomized, placebo-controlled clinical study.

Item
http://www.wikidata.org/entity/Q34618210
The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.Pharmacokinetics, efficacy and safety of aleglitazar for the treatment of type 2 diabetes with high cardiovascular risk.Discontinued in 2013: diabetic drugs.Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions.Safety of Anti-Diabetic Therapies on Bone.PPAR agonists for the treatment of cardiovascular disease in patients with diabetes.Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside.A review of the efficacy and safety of oral antidiabetic drugs
P2860

Pharmacokinetics, pharmacodynamics, and tolerability of aleglitazar in patients with type 2 diabetes: results from a randomized, placebo-controlled clinical study.

Item
http://www.wikidata.org/entity/Q34618210
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@ast
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@en
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@nl
type
label
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@ast
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@en
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@nl
prefLabel
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@ast
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@en
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P921
P356
P1433
P1476
Pharmacokinetics, pharmacodyna ...... ebo-controlled clinical study.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P6179
P698
P921